Can SJS Cause Low Platelets?
Yes, Stevens-Johnson syndrome (SJS) can cause thrombocytopenia (low platelet count), though it is recognized as an uncommon complication of the acute phase of the disease.
Hematologic Complications in SJS/TEN
The U.K. guidelines for management of SJS/TEN explicitly state that "anaemia and leucopenia are common complications of the acute phase of SJS/TEN" 1. While these guidelines emphasize anemia and white blood cell abnormalities (particularly neutropenia), they do not specifically highlight thrombocytopenia as a common finding.
However, multiple case reports and research studies document thrombocytopenia occurring in SJS:
Evidence of Thrombocytopenia in SJS
Pancytopenia (including low platelets) can occur: A 2024 case report describes a patient with SJS who developed pancytopenia affecting all three cell lines, including platelets 2. The authors note this is "an exceedingly rare occurrence" but document that the pancytopenia resolved without requiring platelet transfusion.
In pediatric lupus patients with SJS: Thrombocytopenia was documented in 2 of 5 pediatric SLE patients who developed SJS 3, suggesting it can be part of the hematologic manifestations.
As a prognostic marker: In patients with malignancies who develop SJS/TEN, lower platelet counts before onset were associated with worse outcomes 4.
In severe cases with HLH: When SJS is complicated by hemophagocytic lymphohistiocytosis, pancytopenia including thrombocytopenia can serve as an early warning sign 5.
Clinical Implications
Monitoring
You should check complete blood counts during the acute phase of SJS, as hematologic abnormalities are common complications that may require intervention.
Mechanism
The pathophysiology likely involves either:
- Direct drug cytotoxicity to bone marrow cells
- Immune-mediated damage to hematopoietic cells 2
Management Considerations
- Most cases of thrombocytopenia in SJS resolve with supportive care and treatment of the underlying condition
- Platelet transfusion is rarely required 2
- If patients are immobile, prophylactic anticoagulation with low molecular weight heparin is recommended unless contraindicated by severe thrombocytopenia 1
The key caveat: While thrombocytopenia can occur in SJS, it is less commonly emphasized than neutropenia and anemia. When present, it typically resolves with appropriate management of the SJS itself.